| Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases |
10 |
| Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications |
8 |
| Lipids and Surfactants: The Inside Story of Lipid-Based Drug Delivery Systems |
8 |
| Biomedical Applications and Toxicological Aspects of Functionalized Carbon Nanotubes |
8 |
| Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery |
7 |
| Theranostic Nanostructures for Ovarian Cancer |
6 |
| Role of Solid-Gas Interface of Nanobubbles for Therapeutic Applications |
6 |
| Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies |
6 |
| Perspectives of Lipid-Based Drug Carrier Systems for Transdermal Delivery |
6 |
| Mannosylated Constructs as a Platform for Cell-Specific Delivery of Bioactive Agents |
5 |
| Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review |
5 |
| Inorganic Nanoparticles for X-Ray Computed Tomography Imaging |
5 |
| Polymer-Based Drug Delivery Systems for Cancer |
4 |
| Dendrimers for Therapeutic Delivery: Compositions, Characterizations, and Current Status |
4 |
| In Situ Forming Depot as Sustained-Release Drug Delivery Systems |
4 |
| Polymeric Micelles for the Treatment of Rheumatoid Arthritis |
4 |
| Inhalational Drug Delivery in Pulmonary Aspergillosis |
4 |
| Polymeric Mixed Micelles: Improving the Anticancer Efficacy of Single-Copolymer Micelles |
4 |
| Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems |
4 |
| Solid Lipid Nanoparticles: Vital Characteristics and Prospective Applications in Cancer Treatment |
4 |
| Intranasal Delivery of Nanotherapeutics/Nanobiotherapeutics for the Treatment of Alzheimer's Disease: A Proficient Approach |
3 |
| Current Developments in Therapeutic Drug Targeting for the Management of Rheumatoid Arthritis: An Emerging Paradigm |
3 |
| Evaluation of Nanocarrier-Based Dry Powder Formulations for Inhalation with Special Reference to Anti-Tuberculosis Drugs |
3 |
| Novel 'Stereoscopic Response' Strategy Can Be Used in Combination Therapy |
2 |
| Peroxisome Proliferated Activated Receptors (PPARs): Opportunities and Challenges for Ocular Therapy |
1 |
| Long-Acting Injectables: Current Perspectives and Future Promise |
1 |
| Smoking Cessation Potential of Smartphone-Assisted Behavioral Therapy Coupled to Programmable Carbon Nanotube Membrane Nicotine Delivery Device |
0 |
